KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Fulgent Genetics (FLGT) Other Non Operating Income (2023 - 2025)

Fulgent Genetics' Other Non Operating Income history spans 3 years, with the latest figure at $44000.0 for Q4 2025.

  • For Q4 2025, Other Non Operating Income rose 528.57% year-over-year to $44000.0; the TTM value through Dec 2025 reached $153000.0, down 72.73%, while the annual FY2025 figure was $153000.0, 72.73% down from the prior year.
  • Other Non Operating Income for Q4 2025 was $44000.0 at Fulgent Genetics, up from -$5000.0 in the prior quarter.
  • Across five years, Other Non Operating Income topped out at $552000.0 in Q3 2024 and bottomed at -$22000.0 in Q4 2023.
  • The 3-year median for Other Non Operating Income is $11000.0 (2024), against an average of $76888.9.
  • The largest YoY upside for Other Non Operating Income was 855.56% in 2025 against a maximum downside of 100.91% in 2025.
  • A 3-year view of Other Non Operating Income shows it stood at -$22000.0 in 2023, then skyrocketed by 131.82% to $7000.0 in 2024, then skyrocketed by 528.57% to $44000.0 in 2025.
  • Per Business Quant, the three most recent readings for FLGT's Other Non Operating Income are $44000.0 (Q4 2025), -$5000.0 (Q3 2025), and $46000.0 (Q2 2025).